Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

European Urology - Tập 61 - Trang 818-825 - 2012
Eugene K. Cha1, Shahrokh F. Shariat1,2, Matthias Kormaksson3, Giacomo Novara4, Thomas F. Chromecki1,5, Douglas S. Scherr1, Yair Lotan6, Jay D. Raman7, Wassim Kassouf8, Richard Zigeuner5, Mesut Remzi9, Karim Bensalah10, Alon Weizer11, Eiji Kikuchi12, Christian Bolenz13, Marco Roscigno14, Theresa M. Koppie15, Casey K. Ng16, Hans-Martin Fritsche17, Kazumasa Matsumoto18
1Department of Urology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA
2Division of Medical Oncology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA
3Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, USA
4University of Padua, Padua, Italy
5Medical University of Graz, Graz, Austria
6University of Texas Southwestern Medical Center; Dallas, TX, USA
7Penn State Milton S. Hershey Medical Center, Hershey, PA, USA
8McGill University, Montreal, Quebec, Canada
9Landeskrankenhaus Weinviertel-Korneuburg, Korneuburg, Austria
10CHU Pontchaillou, Rennes, France
11University of Michigan, Ann Arbor, MI USA
12Keio University School of Medicine, Tokyo, Japan
13Mannheim Medical Center, University of Heidelberg, Mannheim, Germany
14Ospedali Riuniti of Bergamo, Bergamo, Italy
15University of California, Davis, School of Medicine, Sacramento, CA, USA
16Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
17Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany
18Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

Tài liệu tham khảo

Novara, 2007, Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers, Cancer, 110, 1715, 10.1002/cncr.22970 Jeldres, 2010, Highly predictive survival nomogram after upper urinary tract urothelial carcinoma, Cancer, 116, 3774, 10.1002/cncr.25122 Shariat, 2010, Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy, BJU Int, 105, 1672, 10.1111/j.1464-410X.2009.09072.x Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361 Novara, 2010, Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study, Eur Urol, 57, 1064, 10.1016/j.eururo.2009.12.029 Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x Fritsche HM, Novara G, Burger M, et al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. In press. http://dx.doi.org/10.1016/j.urolonc.2010.07.010. Wheat JC, Weizer AZ, Wolf JS Jr, et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. In press. http://dx.doi.org/10.1016/j.urolonc.2010.01.001. Otto, 2011, Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients, World J Urol, 29, 487, 10.1007/s00345-011-0645-8 Weiser, 2008, Individualized prediction of colon cancer recurrence using a nomogram, J Clin Oncol, 26, 380, 10.1200/JCO.2007.14.1291 Lughezzani, 2010, Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature, Eur Urol, 58, 687, 10.1016/j.eururo.2010.07.034 Greene, 2002 Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Raman, 2010, Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy, Eur Urol, 57, 1072, 10.1016/j.eururo.2009.07.002 Harrell, 1982, Evaluating the yield of medical tests, JAMA, 247, 2543, 10.1001/jama.1982.03320430047030 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 Favaretto, 2010, The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center, Eur Urol, 58, 574, 10.1016/j.eururo.2010.07.003 Ouzzane, 2011, Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy, Eur Urol, 60, 1258, 10.1016/j.eururo.2011.05.049 Chromecki, 2012, The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy, Eur Urol, 61, 245, 10.1016/j.eururo.2011.09.017 Shariat, 2008, An updated catalog of prostate cancer predictive tools, Cancer, 113, 3075, 10.1002/cncr.23908 Shariat, 2008, Nomograms for bladder cancer, Eur Urol, 54, 41, 10.1016/j.eururo.2008.01.004 Hellenthal, 2009, Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration, J Urol, 182, 900, 10.1016/j.juro.2009.05.011 Burger, 2011, No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study, World J Urol, 29, 465, 10.1007/s00345-011-0705-0 Vickers, 2009, Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach, Cancer, 115, 5460, 10.1002/cncr.24615